Marlborough biotech firm Advanced Cell Technology said it has picked up $30 million in capital through a common stock purchase agreement with a Chicago-based investment firm. The deal, with Lincoln ...

WASHINGTON (KRT) ­ A Massachusetts company said Sunday that it had for the first time cloned an early human embryo in an experiment intended to eventually produce matching cells for patients with a ...

For only the second time, the Food and Drug Administration approved a company’s request to test an embryonic stem cell-based therapy on human patients. more Advanced Cell Technology (ACT), based in ...

Ocata Therapeutics of Marlborough, which researches treatments for eye diseases, has agreed to be sold to Astellas Pharma Inc. of Japan for $379 million, the two companies announced late Monday.